Marker Therapeutics Inc (MRKR)

[Phantom Lord]

DICE went public in September of last year. Obviously they aren't going to have any splits. While we have the pending R/S that will probably happen by February of next year you can't really take any of Marker's history prior to 2018 into account. So Marker essentially has no splits in it current form either. If you are going to make comparisons between two completely different companies at least try to make them in good faith.

We all know management matters but it doesn't matter who is in management if data is good. DICE didn't increase over 100% because their management team is a bunch of saints. They release positive data and reported that they are advancing trials into the next phase. That is the only reason for the increase. Stop trying to pretend otherwise unless you can provide real examples to prove your point.